BENITEC BIOPHARMA INC's ticker is BNTC and the CUSIP is 08205P100. A total of 19 filers reported holding BENITEC BIOPHARMA INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $5,113 | +13.6% | 21,438 | 0.0% | 0.00% | – |
Q1 2023 | $4,500 | -38.3% | 21,438 | -50.0% | 0.00% | – |
Q4 2022 | $7,288 | -8.9% | 42,876 | +100.0% | 0.00% | – |
Q3 2022 | $8,000 | -68.0% | 21,438 | 0.0% | 0.00% | – |
Q2 2022 | $25,000 | -50.0% | 21,438 | 0.0% | 0.00% | – |
Q1 2022 | $50,000 | -9.1% | 21,438 | +2.1% | 0.00% | – |
Q4 2021 | $55,000 | -26.7% | 21,000 | 0.0% | 0.00% | – |
Q3 2021 | $75,000 | -15.7% | 21,000 | 0.0% | 0.00% | – |
Q2 2021 | $89,000 | – | 21,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SUVRETTA CAPITAL MANAGEMENT, LLC | 769,000 | $130,730 | 0.01% |
Virtu Financial LLC | 80,867 | $14 | 0.00% |
FRANKLIN RESOURCES INC | 10,000,000 | $1,700,000 | 0.00% |
Walleye Capital LLC | 344,015 | $58,483 | 0.00% |
WealthTrust Axiom LLC | 12,950 | $2,202 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
UBS Group AG | 1,274 | $217 | 0.00% |
Rockefeller Capital Management L.P. | 300 | $0 | 0.00% |
TWO SIGMA INVESTMENTS, LP | 28,953 | $4,922 | 0.00% |
Rosenberg Matthew Hamilton | 381 | $65 | 0.00% |